MYOV Overview
Upcoming Projects (MYOV)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (MYOV)
-
Don’t see a project related to the company you care about? Create your own!
Expired Projects (MYOV)
-
A Second View: Discussing Myovant Sciences' Myfembree as a treatment for heavy menstrual bleeding associated with uterine fibroids
Ticker: MYOV
Execute By: Aug 31, 2021
Upcoming & Overdue Catalysts (MYOV)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (MYOV)
-
Myovant Sciences' (MYOV) ORGOVYX (Relugolix) in Uterine fibroids PDUFA date set for June 1, 2021
Ticker: MYOV
Occurred on: May 26, 2021 -
Myovant Sciences (MYOV) Announces $218MM Pricing of Initial Public Offering
Ticker: MYOV
Occurred on: Oct 27, 2016
Strategic Initiatives (MYOV)
-
Myovant Sciences (MYOV) and Pfizer (PFE) Announce Collaboration to Develop and Commercialize Relugolix in Oncology and Women’s Health
Tickers: MYOV, PFE
Announcement Date: Dec 28, 2020
